Qiagen NV | QIA - Ordinary Share Capital


Qiagen NV reported $216.56M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.65M 2.33M Mar/2026
Qiagen NV USD 216.56M 284.67K Dec/2025
Revvity USD 111.8M 1.57M Mar/2026
Tectonic Therapeutic USD 18.83M 92.19K Mar/2026
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026